• Mitochondrial Potential as a Translational Cancer Readout

  2026-08-11

  A mechanistic and strategic guide to using ΔΨm as a decision-quality endpoint in cancer research, linking hypoxia-activated Cyclin K degradation and phototherapy with rigorous mitochondrial function analysis, apoptosis assay design, and translational validation.

• From SepM Mechanism to Translational Protein Control

  2026-08-10

  A thought-leadership guide connecting SepM mutation biology in Streptococcus mutans with rigorous protein workflow design. It shows how a Triple color protein ladder can strengthen SDS-PAGE, Western blot, and translational decision-making without overstating what a molecular weight marker can prove.

• Dimetridazole Workflows for AMR Assays

  2026-08-09

  Dimetridazole supports more than a conventional antimicrobial screen: it can reveal membrane injury, combination synergy, quorum-sensing effects, and infection-model responses. This practical guide translates recent multidrug-resistant E. coli findings into reproducible bacterial culture assay, biofilm, and invertebrate workflows.

• Lipid Peroxidation (MDA) Assay Kit for Liver Injury

  2026-08-08

  The Lipid Peroxidation (MDA) Assay Kit provides a practical way to quantify malondialdehyde while placing the result in a mechanistic framework for doxorubicin-induced liver injury. Learn how to combine MDA measurement with ferroptosis, oxidative stress, and autophagy endpoints for stronger biological conclusions.

• SLC2A5 Fructose Metabolism in Primary CNS Lymphoma

  2026-08-07

  This 2026 Advanced Science study uses single-cell RNA and B-cell receptor profiling to connect glucose-poor, hypoxic conditions in primary central nervous system lymphoma with SLC2A5-mediated fructose metabolism. Functional experiments identify SLC2A5 activity in lymphoma cells and tumor-supportive macrophages as a potential metabolic vulnerability, while also linking the microenvironment to T-cell dysfunction.

• Ambroxol Modulation of Nav1.8, TRPV1, and TRPA1 in Neuropath

  2026-08-07

  This study systematically characterizes ambroxol’s modulatory effects on human and rat Nav1.8 sodium channels and the irritant receptors TRPV1 and TRPA1, providing mechanistic insight into its topical analgesic actions. The findings clarify species-specific channel inhibition and reveal that ambroxol can attenuate capsaicin-induced TRPV1 responses, which is relevant for translational research targeting pain signaling pathways.

• Saturated Phosphatidic Acids Drive mTORC1 ISR in Hepatic Glu

  2026-08-06

  This study clarifies how saturated phosphatidic acids trigger mTORC1-mediated integrated stress response (ISR) in hepatocytes, contributing to glucolipotoxicity—a key mechanism in metabolic liver disease. The findings highlight a new molecular link between lipid/glucose overload and hepatocyte death, offering a targeted framework for experimental intervention.

• Beclin1 Deficiency Mitigates DOX-Induced Liver Injury via Fe

  2026-08-06

  This study uncovers the role of Beclin1 in promoting ferroptosis and autophagy during doxorubicin-induced liver injury, demonstrating that Beclin1 deficiency or DHODH overexpression alleviates hepatic oxidative stress and cellular damage. These findings reveal new mechanistic targets for reducing chemotherapeutic hepatotoxicity and refining approaches for oxidative stress biomarker assay and lipid peroxidation measurement.

• Iron-Dependent KDM4D Regulates MSC Quiescence via PI3K-Akt-F

  2026-08-05

  This study uncovers how iron-dependent KDM4D demethylase activity shapes the balance between quiescence and activation in mesenchymal stem cells (MSCs) via the PI3K-Akt-Foxo1 pathway. The findings provide mechanistic insight into the epigenetic impact of iron deficiency on bone metabolism and highlight actionable targets for bone disorder research.

• Isorhamnetin Enhances Oocyte Maturation via PI3K/Akt Activat

  2026-08-05

  This study demonstrates that isorhamnetin, a dietary flavonoid, promotes oocyte maturation by activating the PI3K/Akt pathway, alleviating oxidative and endoplasmic reticulum stress, and reducing apoptosis. These mechanistic findings hold promise for optimizing in vitro oocyte maturation protocols and advancing infertility research.

• Directed Generation of RV-like Cardiomyocytes from hPSCs

  2026-08-04

  Saito et al. present a protocol to selectively induce right ventricular-like cardiomyocytes from human pluripotent stem cells by modulating BMP signaling during mesoderm induction. This methodological advance enables chamber-specific cardiac disease modeling and expands the utility of hPSC-derived cardiomyocytes in precision research.

• Quercetin Protects Cataract Lenses via Hippo Pathway Modulat

  2026-08-04

  This study demonstrates that quercetin mitigates cataract formation in a UVB-induced mouse model by suppressing Hippo pathway activity, enhancing lens epithelial cell survival and antioxidative capacity. The findings clarify mechanistic links between Hippo signaling and cataractogenesis, suggesting new pharmacological intervention strategies.

• Quercetin Protects Cataract Lenses via Hippo Pathway Modulat

  2026-08-03

  This study reveals that quercetin mitigates cataract progression by inactivating the Hippo signaling pathway and promoting lens epithelial cell survival. These mechanistic insights highlight a promising non-surgical strategy for cataract intervention, opening avenues for future research in pathway-targeted ocular therapeutics.

• N6-Methyl-dATP in Epigenetic Research: Protocols & Innovatio

  2026-08-03

  N6-Methyl-dATP from APExBIO enables high-fidelity DNA replication studies and advanced methylation modification research, empowering investigators to dissect epigenetic mechanisms in leukemia and beyond. This article provides actionable workflows, troubleshooting guidance, and unique insights that bridge foundational research with translational applications.

• DRD4 Drives Chemo-Resistance via PI3K/Akt/β-Catenin in Liver

  2026-08-02

  Recent work demonstrates that dopamine receptor D4 (DRD4) enhances chemoresistance and cancer stem cell-like properties in hepatocellular carcinoma by activating the PI3K/Akt/β-catenin signaling axis. Targeting DRD4-mediated pathway activation may offer new strategies to overcome therapy resistance in liver cancer.

8187 records 5/546 page Previous Next 12345 下5页 Last page